Key result
Adrenalectomy for primary aldosteronism in elderly patients achieves comparable biochemical cure but more persistent hypertension.
Why the study?
Primary aldosteronism in the elderly has increased in importance with population aging, but characteristics and postoperative outcomes after adrenalectomy remain unclear.
Does adrenalectomy provide comparable biochemical cure and clinical outcomes in elderly patients with primary aldosteronism compared to nonelderly patients?
Cohort
Does adrenalectomy provide comparable biochemical cure and clinical outcomes in elderly patients with primary aldosteronism compared to nonelderly patients?
Adrenalectomy provides comparable biochemical cure in elderly patients with primary aldosteronism as in nonelderly patients, though it carries higher risks of persistent hypertension, hyperkalemia, and renal impairment.
Answers are grounded in this paper and cite their sources.
Supports biochemical benefit of adrenalectomy in elderly primary aldosteronism despite higher persistent hypertension; leaves open randomized outcome trials.
Context: Primary aldosteronism (PA) in the elderly has increased in importance in association with population aging. Objective: To investigate the characteristics and outcomes of elderly patients with PA undergoing adrenalectomy. Patients and Methods: Using a database of patients with PA who underwent adrenal venous sampling (AVS), we compared elderly patients (≥65 years old) with nonelderly patients (<65 years old) in terms of characteristics, subtype classification in ACTH-stimulated AVS, and outcomes after adrenalectomy. Results: The elderly group had a higher prevalence of comorbidities than the nonelderly group. The proportion of the unilateral subtype [defined as a lateralization index (LI) >4] was comparable between the age groups. In patients who received adrenalectomy, biochemical cure was comparable between the groups, whereas persistent hypertension was more common in the elderly group. The prevalences of hyperkalemia and renal impairment (chronic kidney disease stage 3b or higher) were higher in the elderly group. Multiple regression analysis showed that the duration of hypertension predicted persistent hypertension and hyperkalemia and that preoperative estimated glomerular filtration rate predicted renal impairment in the elderly group. LI >4 in AVS was an independent predictor of biochemical cure after adrenalectomy in the elderly group but not in the nonelderly group. Age was negatively associated with biochemical cure in patients with LI ≤4. Conclusion: Adrenalectomy contributes to biochemical improvement in elderly patients if determined in accordance with AVS. The treatment strategy should be determined considering the high postoperative incidence of persistent hypertension and hyperkalemia in elderly patients with a long history of hypertension or renal impairment in those with reduced renal function.
No takes yet. Share an insight, caveat, or question.
Takeda et al. (2018) conducted a cohort in Primary aldosteronism. Elderly age (≥65 years) vs. Nonelderly age (<65 years) was evaluated on Biochemical cure and postoperative outcomes (persistent hypertension, hyperkalemia, renal impairment). Elderly patients with primary aldosteronism undergoing adrenalectomy achieved comparable biochemical cure to nonelderly patients, but had higher rates of persistent hypertension and hyperkalemia.
Synapse has enriched 10 related papers. Consider them for comparative context: